Women’s health innovation is accelerating. From AI enabled diagnostics to personalised care pathways, FemTech is reshaping how products are built, tested and adopted. At the same time, regulation, data protection and investment scrutiny are growing, which raises new questions for founders, investors and corporates across the sector.

Over the coming weeks, we’ll release an eight part article series from our cross sector Life Sciences, Technology and Consumer Goods teams – leading up to our flagship London event on 12 May 2026, with a final article to follow after the event.

Available Articles